Articles (12) Publications in which a researcher has participated

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Ausencia de ADN de herpesvirus humano 6 en LCR, mediante técnica de PCR anidada, en pacientes con eesclerosis múltiple

    Revista Clinica Espanola, Vol. 202, Núm. 11, pp. 588-591

  3. Bacteriemia en una niña con rabdomiosarcoma

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 20, Núm. 2, pp. 85-87

  4. Bacteriemia nosocomial en el paciente adulto. Estudio de costes asociados

    Revista Clinica Espanola, Vol. 202, Núm. 9, pp. 476-484

  5. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells

    AIDS, Vol. 16, Núm. 11, pp. 1467-1478

  6. Identification and broad dissemination of the CTX-M-14 β-lactamase in different Escherichia coli strains in the Northwest Area of Spain

    Journal of Clinical Microbiology, Vol. 40, Núm. 11, pp. 4030-4036

  7. In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 20, Núm. 1, pp. 25-27

  8. Infection with retroviruses other than HIV-1 in Spain: A retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II

    HIV Clinical Trials, Vol. 3, Núm. 5, pp. 397-402

  9. Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus-negative patients from Vigo, Spain

    Clinical Infectious Diseases, Vol. 34, Núm. 7, pp. 918-921

  10. Onychomycosis due to Onychocola canadensis: Report of the first two Spanish cases

    Medical Mycology, Vol. 40, Núm. 2, pp. 209-212

  11. Prevalencia de genotipos del virus de la hepatitis C en el área de El Ferrol (la Coruña)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 20, Núm. 5, pp. 200-204

  12. Prevention of cytomegalovirus disease after heart transplantation: Preemptive therapy with 7 days' intravenous ganciclovir

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 69-70